InterCure Ltd. Stock price

Equities

INCR

IL0011063760

Healthcare Facilities & Services

Market Closed - TEL AVIV STOCK EXCHANGE 11:24:58 2024-03-28 am EDT 5-day change 1st Jan Change
955 ILa +4.95% Intraday chart for InterCure Ltd. +16.91% +106.22%
Sales 2021 219.68 80.49K Sales 2022 388.68 142K Capitalization 551M 202B
Net income 2021 4M 1.47B Net income 2022 44M 16.12B EV / Sales 2021 3,844,919 x
Net cash position 2021 87.64M 32.11B Net Debt 2022 22.37M 8.2B EV / Sales 2022 1,473,908 x
P/E ratio 2021
207 x
P/E ratio 2022
12.2 x
Employees 370
Yield 2021 *
-
Yield 2022
-
Free-Float 64.2%
More Fundamentals * Assessed data
Dynamic Chart
1 day+4.95%
1 week+20.95%
Current month+32.80%
1 month+33.38%
3 months+107.79%
6 months+60.77%
Current year+106.22%
More quotes
1 week
850.00
Extreme 850
991.00
1 month
625.00
Extreme 625
991.00
Current year
440.00
Extreme 440
991.00
1 year
395.00
Extreme 395
991.00
3 years
395.00
Extreme 395
3 100.00
5 years
395.00
Extreme 395
5 374.71
10 years
124.58
Extreme 124.5792
6 317.95
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 18-09-30
Director of Finance/CFO 45 20-02-29
Sales & Marketing - 22-10-31
Members of the board TitleAgeSince
Chairman 81 18-08-31
Chief Executive Officer 53 18-09-30
Director/Board Member 62 20-10-31
More insiders
Date Price Change Volume
24-03-28 955 +4.95% 360,349
24-03-27 910 -0.90% 222,688
24-03-26 918.3 -0.02% 210,558
24-03-25 918.5 +12.44% 556,010
24-03-21 816.9 +3.46% 423,812

Delayed Quote TEL AVIV STOCK EXCHANGE, March 28, 2024 at 11:24 am EDT

More quotes
InterCure Ltd is an Israel-based company primarily enagged in cannabis industry. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.
More about the company

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock InterCure Ltd. - TEL AVIV STOCK EXCHANGE